Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 5/2020

Inhalt (25 Artikel)

Open Access Review – Cancer Research

Role of the autophagy-related marker LC3 expression in hepatocellular carcinoma: a meta-analysis

Yu-Chen Meng, Xiao-Li Lou, Li-Yuan Yang, Dong Li, Yan-Qiang Hou

Original Article – Cancer Research

Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes

Wenzhen Xie, Haibo Zhou, Qian Han, Tong Sun, Chuang Nie, Jia Hong, Rongrong Wei, Anastasiia Leonteva, Xu Han, Jing Wang, Xinyu Du, Lin Zhu, Yashuang Zhao, Wenjing Tian, Yingwei Xue

Open Access Original Article – Cancer Research

Significance of unphosphorylated and phosphorylated heat shock protein 27 as a prognostic biomarker in pancreatic ductal adenocarcinoma

Richard Drexler, Kim C. Wagner, Mirco Küchler, Bernd Feyerabend, Moritz Kleine, Karl J. Oldhafer

Open Access Original Article – Cancer Research

The function of Piezo1 in colon cancer metastasis and its potential regulatory mechanism

Yanhua Sun, Ming Li, Guangjie Liu, Xue Zhang, Lianghui Zhi, Jing Zhao, Guiying Wang

Open Access Original Article – Cancer Research

Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations

Ivonne Regel, Melanie Eichenmüller, Ujjwal Mukund Mahajan, Beate Hagl, Simone Benitz, Beate Häberle, Christian Vokuhl, Dietrich von Schweinitz, Roland Kappler

Review – Clinical Oncology

Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review

Rezwanul Hasan Rana, Fariha Alam, Khorshed Alam, Jeff Gow

Open Access Original Article – Clinical Oncology

Predictors of the regional variation of prostatectomy or radiotherapy: evidence from German cancer registries

Daniel Medenwald, Julia Ferencz, Dirk Vordermark

Original Article – Clinical Oncology

LOC646329 long non-coding RNA sponges miR-29b-1 and regulates TGFβ signaling in colorectal cancer

Amir-Reza Javanmard, Sadat Dokanehiifard, Mehrdad Bohlooli, Bahram M. Soltani

Original Article – Clinical Oncology

Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors

Kazuki Takada, Yasuto Yoneshima, Kentaro Tanaka, Isamu Okamoto, Mototsugu Shimokawa, Sho Wakasu, Shinkichi Takamori, Gouji Toyokawa, Taro Oba, Atsushi Osoegawa, Tetsuzo Tagawa, Yoshinao Oda, Yoichi Nakanishi, Masaki Mori

Original Article – Clinical Oncology

Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy

Ciro Franzese, Tiziana Comito, Davide Franceschini, Mauro Loi, Elena Clerici, Pierina Navarria, Fiorenza De Rose, Lucia Di Brina, Pietro Mancosu, Giacomo Reggiori, Stefano Tomatis, Marta Scorsetti

Original Article – Clinical Oncology

The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitors

Angelo Castello, Luca Toschi, Sabrina Rossi, Emanuela Mazziotti, Egesta Lopci

Original Article – Clinical Oncology

Thoracic solitary fibrous tumors: an analysis of 70 patients who underwent surgical resection in a single institution

Chao Zhou, Wentao Li, Jinchen Shao, Jikai Zhao

Original Article – Clinical Oncology

Radiomic profiles in diffuse glioma reveal distinct subtypes with prognostic value

Peng Lin, Yu-ting Peng, Rui-zhi Gao, Yan Wei, Xiao-Jiao Li, Su-Ning Huang, Ye-Ying Fang, Zhu-Xin Wei, Zhi-Guang Huang, Hong Yang, Gang Chen

Original Article – Clinical Oncology

Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer

Zekai Shu, Baiqiang Dong, Lei Shi, Wei Shen, Qingqing Hang, Jin Wang, Yuanyuan Chen

Open Access Original Article – Clinical Oncology

Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study

Stefano Guadagni, Marco Clementi, Andrew R. Mackay, Enrico Ricevuto, Giammaria Fiorentini, Donatella Sarti, Paola Palumbo, Panagiotis Apostolou, Ioannis Papasotiriou, Francesco Masedu, Marco Valenti, Aldo Victor Giordano, Gemma Bruera

Original Article – Clinical Oncology

Optimal method for measuring invasive size that predicts survival in invasive mucinous adenocarcinoma of the lung

Tomonari Oki, Keiju Aokage, Shogo Nomura, Kenta Tane, Tomohiro Miyoshi, Norihiko Shiiya, Kazuhito Funai, Masahiro Tsuboi, Genichiro Ishii

Original Article – Clinical Oncology

The prognostic factors of recurrence and survival in female patients with lung adenocarcinoma and breast cancer

Ying-Yi Chen, Yi-Jhih Huang, Hsu-Kai Huang, Hung Chang, Shih-Chun Lee, Yi-Shing Shieh, Tsai-Wang Huang

Original Article – Clinical Oncology

ALK detection in lung cancer: identification of atypical and cryptic ALK rearrangements using an optimal algorithm

Yuanyuan Liu, Shafei Wu, Xiaohua Shi, Zhiyong Liang, Xuan Zeng

Original Article – Clinical Oncology

Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness study

Rui Pedro Marques, Ana Rita Godinho, Peter Heudtlass, Helena Luna Pais, António Quintela, Ana Paula Martins

Original Article – Clinical Oncology

Treatment strategies for recurrent ovarian cancer in older adult patients in Japan: a study based on real-world data

Mayumi Kobayashi Kato, Mayu Yunokawa, Seiko Bun, Tatsunori Shimoi, Kan Yonemori, Naoyuki Miyasaka, Tomoyasu Kato, Kenji Tamura

Original Article – Clinical Oncology

Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery

In Seong Jeong, Jong-Lyel Roh, Kyung-Ja Cho, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim

Original Article – Clinical Oncology

The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis

Manabu Yamamoto, Mototsugu Shimokawa, Daisuke Yoshida, Shohei Yamaguchi, Mitsuhiko Ohta, Akinori Egashira, Masahiko Ikebe, Masaru Morita, Yasushi Toh

Original Article – Clinical Oncology

Microwave ablation for non-small cell lung cancer with synchronous solitary extracranial metastasis

Yang Ni, Xin Ye, Xia Yang, Guanghui Huang, Wenhong Li, Jiao Wang, Xiaoying Han, Zhigang Wei, Min Meng, Zhigeng Zou

Correction

Correction to: The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma

Wei Li, Wei Wang, Mani Si, Linfei Han, Qinglei Gao, Aiyue Luo, Yan Li, Yunping Lu, Shixuan Wang, Ding Ma

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.